Literature DB >> 19543904

15-Year review of laryngeal and oral dysplasias and progression to invasive carcinoma.

Patrick M Spielmann1, T Palmer, L McClymont.   

Abstract

The objective of this study is to identify a management or follow-up strategy for patients with laryngeal and oral dysplasia. A chart review of all patients with laryngeal and oral dysplasia over a 15-year period was performed. All patients were followed for a minimum period of 5 years from initial diagnosis of oropharyngeal or laryngeal dysplasia. If invasive carcinoma was demonstrated on subsequent biopsies, the exact time of this was recorded and Kaplan-Meier survival curves were plotted. In the laryngeal cohort, 45 patients were identified, 15 (33%) developed carcinoma, 7 of 30 patients (23%) with mild or moderate dysplasia, compared with 8 of 15 (53%) with severe dysplasia or CIS (P = 0.01). Thirteen of the carcinomas (87%) developed within 36 months of original biopsy. In the oral cohort, 32 patients were identified, 17 (53%) developed carcinoma, 1 of 9 patients (11%) with mild dysplasia, compared with 8 of 12 (67%) with severe dysplasia and 8 of 10 (80%) with CIS (P < 0.001). Fifteen of the 17 patients (88%) developed carcinoma within 36 months of original biopsy. In conclusion, although numbers are small, our results show that mild and moderate laryngeal dysplasia behaves differently to severe dysplasia and CIS. Mild oral dysplasia also behaves differently to severe dysplasia or CIS. In general, progress to malignancy happens within a 3-year period. Severe dysplasia or CIS should be managed aggressively.

Entities:  

Mesh:

Year:  2009        PMID: 19543904     DOI: 10.1007/s00405-009-1013-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

Review 1.  Laser surgery as a treatment for oral leukoplakia.

Authors:  J Ishii; K Fujita; T Komori
Journal:  Oral Oncol       Date:  2003-12       Impact factor: 5.337

Review 2.  Laryngeal dysplasia: aetiology and molecular biology.

Authors:  Maziar Sadri; Jeremy McMahon; Andrew Parker
Journal:  J Laryngol Otol       Date:  2005-12-14       Impact factor: 1.469

3.  Management of potentially malignant oral mucosal lesions by consultant UK oral and maxillofacial surgeons.

Authors:  J J Marley; C G Cowan; P J Lamey; G J Linden; N W Johnson; K A Warnakulasuriya
Journal:  Br J Oral Maxillofac Surg       Date:  1996-02       Impact factor: 1.651

Review 4.  The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up.

Authors:  P S van der Hem; J M Nauta; J E van der Wal; J L N Roodenburg
Journal:  Oral Oncol       Date:  2005-01       Impact factor: 5.337

Review 5.  Interventions for treating oral leukoplakia.

Authors:  G Lodi; A Sardella; C Bez; F Demarosi; A Carrassi
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

6.  Predicting cancer development in oral leukoplakia: ten years of translational research.

Authors:  J J Lee; W K Hong; W N Hittelman; L Mao; R Lotan; D M Shin; S E Benner; X C Xu; J S Lee; V M Papadimitrakopoulou; C Geyer; C Perez; J W Martin; A K El-Naggar; S M Lippman
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

7.  Compact endoscopy of the larynx.

Authors:  Christoph Arens; Hiltrud Glanz; Thomas Dreyer; Karin Malzahn
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-02       Impact factor: 1.547

Review 8.  Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer.

Authors:  P Dey; D Arnold; R Wight; K MacKenzie; C Kelly; J Wilson
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 9.  Institutional and comprehensive review of laryngeal leukoplakia.

Authors:  Jason S Isenberg; Daniel L Crozier; Seth H Dailey
Journal:  Ann Otol Rhinol Laryngol       Date:  2008-01       Impact factor: 1.547

10.  OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome.

Authors:  S Staibano; F Merolla; D Testa; R Iovine; M Mascolo; V Guarino; M D Castellone; M Di Benedetto; V Galli; S Motta; R M Melillo; G De Rosa; M Santoro; A Celetti
Journal:  Br J Cancer       Date:  2007-11-06       Impact factor: 7.640

View more
  5 in total

Review 1.  [Dysplasia and laryngeal carcinoma in situ].

Authors:  U Schroeder; M P E Gebhard; B Wollenberg
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

2.  A decade of laryngeal dysplasia in Paisley, Scotland.

Authors:  Jenny Montgomery; Aileen White
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-08       Impact factor: 2.503

Review 3.  [Morphology of non cutaneous head and neck squamous cell carcinoma].

Authors:  W Weichert; S Ihrler; M Boxberg; A Agaimy; M Mollenhauer; A Hartmann
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

4.  Oral dysplasia: biomarkers, treatment, and follow-up.

Authors:  Paul Nankivell; Hisham Mehanna
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

5.  CO(2) laser versus cold steel margin analysis following endoscopic excision of glottic cancer.

Authors:  Fawaz M Makki; Matthew H Rigby; Martin Bullock; Timothy Brown; Robert D Hart; Jonathan Trites; Michael L Hinni; S Mark Taylor
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.